Sinovac Biotech Faces Financial Downturn in 2024
Sinovac's 2024 revenue drops amidst market challenges, with ongoing vaccine development and international market expansions.
- Latest
- Trending
Sinovac's 2024 revenue drops amidst market challenges, with ongoing vaccine development and international market expansions.
Treace Medical Concepts reported a 6% rise in Q2 revenue to $44.5M, driven by new products and a growing surgeon ...
Thai banks finance Myanmar junta's war, UN expert reports. Financial support prolongs conflict and human rights abuses. International call to ...
KKR acquires a $2.1B multifamily real estate portfolio from Quarterra, spanning 5,200 units across 8 states, signaling market recovery.
"Pemex's Olmeca refinery faces delays, high costs; operational by end of 2023 unlikely. Mexico's energy independence goals challenged."
"NASA STAR program open for applications until June 28. Join elite researchers in space biology training and experiment opportunities in ...
"Ethereum defies a sinking crypto market while Bitcoin and meme coins plummet. Market experts are divided over the future of ...
NASA delays Boeing Starliner's return from ISS due to tech issues; no new date set. Multiple thruster failures and helium ...
BYD highlights advanced renewable energy solutions at The Smarter E Europe, unveils new innovations and celebrates UEFA Euro 2024 E-Mobility ...
Nesto acquires CMLS Group, merging to form a firm with 1,000+ employees managing $60B in mortgages. CEO Malik Yacoubi to ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.